# A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer

> **NCT05913115** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 6 (actual)

## Conditions studied

- Gastric or Gastroesophageal Cancer

## Interventions

- **DRUG:** FPA144

## Key facts

- **NCT ID:** NCT05913115
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-12
- **Primary completion:** 2018-06-19
- **Final completion:** 2018-06-19
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05913115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05913115, "A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05913115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*